(Q24632001)
Statements
Design and development of TT30, a novel C3d-targeted C3/C5 convertase inhibitor for treatment of human complement alternative pathway-mediated diseases (English)
0 references
27 October 2011
0 references
118
0 references
17
0 references
4705-13
0 references
1 reference
1 reference
1 reference
1 reference